The Supreme Court today said it will review, during its term beginning in October, a federal appeals court decision that held the Affordable Care Act's individual mandate unconstitutional. 

Twenty states and the District of Columbia petitioned the Supreme Court to quickly review the decision, which sent the case back to the district court in Texas for the judge to take a “careful, granular approach” to determining which of the law's provisions could survive without the mandate.

In January, the AHA — joined by the Federation of American Hospitals, Catholic Health Association of the United States, Association of American Medical Colleges, and America's Essential Hospitals —  filed a friend-of-the-court brief urging the Supreme Court to review the case this term. Thirty-three state hospital associations also filed a friend-of-the-court brief urging the Supreme Court to review the case this term. 

“The 20 million Americans who have gained health insurance under the Affordable Care Act deserve to be secure in their coverage,” said AHA President and CEO Rick Pollack. “While today’s Supreme Court decision to review the challenge to the ACA brings us one step closer to the resolution patients need, these critical coverage gains will remain in unnecessary limbo without expedited review. We strongly urge a prompt decision in favor of the ACA and its protections for patients with pre-existing conditions, expansion of the Medicaid program, creation of new and innovative models of care and many other critical benefits. America’s hospitals and health systems and the patients we serve are ready to put this legal fight behind us – for good.”

For more on the appeals court decision, see the AHA's December statement

Headline
The AHA submitted a statement for the record to the House Ways and Means Committee for its April 28 hearing with health system CEOs.In the statement, the AHA…
Headline
The AHA again is asking the Health Resources and Services Administration to take action after Eli Lilly warned hospitals that they could lose access to…
Headline
The administration Apri 23 reached a most-favored-nation drug pricing agreement with Regeneron, the maker of the popular cholesterol medicine Praluent. This is…
Headline
The AHA April 23 released a blog responding to a report issued April 22 by Paragon Health Institute. The blog highlights how the report relies on a long list…
Blog
Public
In think‑tank reports, like the one released this week by Paragon Health Institute, hospitals are often reduced to abstractions — payment rates, charts,…
Headline
The Centers for Medicare & Medicaid Services announced in a memo April 21that it is delaying implementation of the Medicare Part D portion of the Better…